Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine

This publication has 10 references indexed in Scilit:

• Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate Vaccine
  Published by American Medical Association (AMA) ,2005
• The Impact of a 9-Valent Pneumococcal Conjugate Vaccine on the Public Health Burden of Pneumonia in HIV-Infected and -Uninfected Children
  Clinical Infectious Diseases, 2005
• Quantitative and Qualitative Antibody Response to Pneumococcal Conjugate Vaccine Among African Human Immunodeficiency Virus-Infected and Uninfected Children
  The Pediatric Infectious Disease Journal, 2005
• Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
  The Lancet, 2005
• A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection
  New England Journal of Medicine, 2003
• Safety and Immunogenicity of a Heptavalent Pneumococcal Conjugate Vaccine in Infants With Human Immunodeficiency Virus Type 1 Infection
  Pediatrics, 2003
• Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal Polysaccharides
  Clinical and Vaccine Immunology, 2003
• Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
  New England Journal of Medicine, 2003
• Pneumococcal Type 22F Polysaccharide Absorption Improves the Specificity of a Pneumococcal-Polysaccharide Enzyme-Linked Immunosorbent Assay
  Clinical and Diagnostic Laboratory Immunology, 2001
• Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children
  The Pediatric Infectious Disease Journal, 2000